Greenwich LifeSciences Provides Updates on Flamingo-01 Phase III Clinical Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. SPGI
4. USO
5. AAPL
6. DELL
7. NIO
8. ENOV
9. AON
10. A

Go back to Greenwich LifeSciences Provides Updates on Flamingo-01 Phase III Clinical Trial
(NASDAQ: GLSI) Delayed: 15.01 +0.06 (0.40%)
Previous Close $14.95    52 Week High $ 
Open $14.56    52 Week Low $ 
Day High $15.08    P/E N/A 
Day Low $14.40    EPS $ 
Volume 98,650